Amicus Therapeutics, Inc. (NASDAQ:FOLD) CEO Sells $90,768.00 in Stock
Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) CEO John F. Crowley sold 11,346 shares of the company’s stock in a transaction dated Friday, June 3rd. The stock was sold at an average price of $8.00, for a total value of $90,768.00. Following the completion of the sale, the chief executive officer now owns 932,807 shares […]
New Zealand General New Zealand Banque Pictet Cie Johnf Crowley Amicus Therapeutics Securities Exchange Commission
Source: etfdailynews.com